0000899243-17-026032.txt : 20171113
0000899243-17-026032.hdr.sgml : 20171110
20171113162606
ACCESSION NUMBER: 0000899243-17-026032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171113
FILED AS OF DATE: 20171113
DATE AS OF CHANGE: 20171113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morningside Venture Investments Ltd
CENTRAL INDEX KEY: 0001543112
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38276
FILM NUMBER: 171196246
BUSINESS ADDRESS:
STREET 1: MCCARTHY LEGAL SERVICES
STREET 2: 1188 CENTRE STREET
CITY: NEWTON CENTRE
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-244-2800
MAIL ADDRESS:
STREET 1: MCCARTHY LEGAL SERVICES
STREET 2: 1188 CENTRE STREET
CITY: NEWTON CENTRE
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001492422
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271537290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
BUSINESS PHONE: 502-241-4114
MAIL ADDRESS:
STREET 1: 6400 WESTWIND WAY
STREET 2: SUITE A
CITY: CRESTWOOD
STATE: KY
ZIP: 40014
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-13
0
0001492422
Apellis Pharmaceuticals, Inc.
APLS
0001543112
Morningside Venture Investments Ltd
2ND FLOOR, LE PRINCCE DE GALLES
3-5 AVENUE DES CITRONNIERS
MC 98000
O9
MONACO
0
0
1
0
Common Stock
2017-11-13
4
C
0
10778303
A
10778303
D
Common Stock
2017-11-13
4
P
0
575000
14.00
A
11353303
D
Series B Preferred Stock
2017-11-13
4
C
0
1054544
0.00
D
Common Stock
494394
0
D
Series C Preferred Stock
2017-11-13
4
C
0
17200000
0.00
D
Common Stock
8063759
0
D
Series D Preferred Stock
2017-11-13
4
C
0
4476275
0.00
D
Common Stock
2098581
0
D
Series E Preferred Stock
2017-11-13
4
C
0
259302
0.00
D
Common Stock
121566
0
D
The Series B, Series C, Series D and Series E Preferred Stock converted into Common Stock on a 2.133-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B, Series C, Series D and Series E Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Louise Mary Garbarino, Jill Marie Franklin, Peter Stuart Allenby Edwards and Raymond Long Sing Tang, the directors of Morningside Venture Investments, Ltd. ("MVIL"), share voting and dispositive control over the shares held by MVIL.
/s/ Louise Mary Garbarino
2017-11-13
/s/ Jill Marie Franklin
2017-11-13